Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2
ABSTRACT New SARS-CoV-2 variants of concern and waning immunity demonstrate the need for a quick and simple prophylactic agent to prevent infection. Low molecular weight heparins (LMWH) are potent inhibitors of SARS-CoV-2 binding and infection in vitro. The airways are a major route for infection an...
Main Authors: | Julia Eder, Marta Bermejo-Jambrina, Killian E. Vlaming, Tanja M. Kaptein, Viktoria Zaderer, E. Marleen Kemper, Doris Wilflingseder, Sietze Reitsma, Godelieve J. de Bree, Danny M. Cohn, Teunis B. H. Geijtenbeek |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-12-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.02558-22 |
Similar Items
-
Not Just Anticoagulation—New and Old Applications of Heparin
by: Lixuan Zang, et al.
Published: (2022-10-01) -
Nebulized heparin for burned patients with inhalation injury: a review
by: Tiberiu Paul Neagu, et al.
Published: (2022-03-01) -
The effect of heparins on plasma concentration of heparin-binding protein: a pilot study
by: Halla Halldorsdottir, et al.
Published: (2024-03-01) -
Heparin-induced thrombocytopenia
by: Shaikh Nissar
Published: (2011-01-01) -
Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients
by: Mahmut Yüksel, et al.
Published: (2009-12-01)